Tara C Knox

Tara Knox serves as a key procurement lead within the NIH National Heart, Lung, and Blood Institute’s Office of Acquisitions, supporting the agency’s mission to accelerate biomedical innovation through strategic procurement of high-precision diagnostic and surgical instrumentation. She manages the acquisition lifecycle for mission-critical laboratory equipment and specialized medical devices used in translational research and public health emergency response, ensuring compliance with federal acquisition regulations while prioritizing technical performance, scalability, and rapid deployment. Her work directly enables cutting-edge research in molecular diagnostics, point-of-care testing, and advanced analytical platforms critical to NHLBI’s scientific priorities. Tara collaborates with a diverse ecosystem of vendors, including manufacturers of analytical laboratory instruments, clinical diagnostics firms, and specialized scientific services providers. She engages with both large-tier suppliers and emerging innovators capable of delivering custom-engineered solutions for complex research environments. Her contracting approach emphasizes performance-based requirements, technical evaluations, and competitive sealed bidding to ensure value and reliability. While no single contractor dominates her portfolio, she consistently seeks partners with proven expertise in FDA-regulated medical devices and ISO 13485-compliant manufacturing. Tara’s procurement patterns reflect a strong preference for open competition, with 100% of her acquisitions designated as “No Set-Aside.” This indicates a focus on technical merit and capability over socioeconomic classifications, though she remains compliant with all federal small business programs. Her approach prioritizes mission readiness and scientific rigor, ensuring that procurement decisions are driven by performance, innovation, and operational suitability rather than socioeconomic preferences. Her primary procurement focus lies within NAICS 621511 (Medical Laboratories), 334516 (Analytical Laboratory Instrument Manufacturing), and 541990 (Other Professional, Scientific, and Technical Services). She routinely acquires next-generation sequencers, mass spectrometers, flow cytometers, and minimally invasive surgical systems, demonstrating deep familiarity with laboratory automation, biosafety standards, and regulatory pathways for diagnostic devices. Her expertise bridges scientific requirements with federal acquisition policy to deliver mission-critical capabilities to NHLBI’s research community.